Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: Hulot, Jean-Sébastien1 ; Salem, Joe-Elie1; Redheuil, Alban1; Collet, Jean-Philippe1; Varnous, Shaida1; Jourdain, Patrick2; Logeart, Damien3; Gandjbakhch, Estelle1; Bernard, Claude4; Hatem, Stéphane N.1; Isnard, Richard1; Cluzel, Philippe1; Le Feuvre, Claude1; Leprince, Pascal1; Hammoud, Nadjib1; Lemoine, François M.4; Klatzmann, David4; Vicaut, Eric5; Komajda, Michel1; Montalescot, Gilles1,5
- المصدر:
European Journal of Heart Failure. Supplements. Nov2017, Vol. 19 Issue 11, p1534-1541. 8p.
No Comments.